Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026)
Avanos Medical (AVNS) posted Income from Continuing Operations of 5100000.0 for Q1 2026, up 492.31% sequentially from 1300000.0 in Q4 2025, and down 22.73% YoY from 6600000.0 in Q1 2025.
Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Avanos Medical has reported Income from Continuing Operations for 14 years, with the latest figure at 5100000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 22.73% year-over-year to 5100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 74400000.0 (up 80.43% YoY) and the FY2025 annual result came in at 72900000.0, up 81.13% from the prior year.
- Income from Continuing Operations advanced to 5100000.0 in Q1 2026 per AVNS's latest filing, from 1300000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 11000000.0 in Q3 2022 and troughed at 397000000.0 in Q4 2024.
- A 5-year average of 25476470.59 and a median of 4300000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 3709.09% in 2024, then jumped 1220.0% in 2025.
- Over 5 years, Income from Continuing Operations stood at 9700000.0 in 2022, then climbed by 13.4% to 11000000.0 in 2023, then tumbled by 3709.09% to 397000000.0 in 2024, then surged by 99.67% to 1300000.0 in 2025, then jumped by 492.31% to 5100000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 5100000.0, 1300000.0, and 1400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -76.80 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | -397.00 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -7.80 Mn |
| Dec 31, 2022 | 9.70 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -25.70 Mn |
| Sep 30, 2021 | -35.30 Mn |
| Jun 30, 2021 | 38.50 Mn |